Trending: JPMorgan's Living Will Found to Have Weaknesses
1349 ET -- JPMorgan is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. Regulators raised doubts about how some of the biggest banks in the U.S. would try to wind themselves down in the event of a failure. The Federal Reserve and the Federal Deposit Insurance Corp. said on Friday the plan, also known as a living will, from JPMorgan Chase had weaknesses. Regulators pointed to concerns about how JPMorgan would unwind derivatives positions in the event of a bankruptcy. Dow Jones & Co. owns Factiva. (matthew.walker@dowjones.com)
(END) Dow Jones Newswires
June 21, 2024 14:04 ET (18:04 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Obesity Drug Stocks: Why It Will Be ‘Exceptionally Difficult’ to Dethrone Eli Lilly and Novo Nordisk
-
What Does Chipotle’s Stock Split Mean for Investors?
-
5 Stocks to Buy Before the Fed Cuts Interest Rates in 2024
-
Markets Brief: Inflation Is Back In the Spotlight
-
What’s Happening In the Markets This Week
-
What a Strong Economy Now Means for the Rest of 2024
-
4 Wide-Moat Stocks to Buy for the Long Term While They’re Undervalued Today
-
Markets Brief: Four Stocks Made Up 80% of the Gains. Can It Last?
-
2 Top E-Commerce Stock Picks
-
Our Top Pick for Investing in US Renewable Energy
-
Micron Earnings: We Raise Our DRAM Forecast and Valuation Behind Stronger Pricing Assumptions
-
10 Undervalued Wide-Moat Stocks
-
What Is a Stock Split?
-
10 Best Value Stocks to Buy for the Long Term
-
A Wide-Moat Stock to Invest in That’s 35% Undervalued
-
Airbus: We Believe Investors May Be Overreacting to Lowered Guidance and Charge